CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 68  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0612
LYS 10.0413
GLU 20.0276
LEU 30.0210
ARG 40.0161
CYS 50.0168
GLN 60.0169
CYS 70.0166
ILE 80.0489
LYS 90.0551
THR 100.0217
TYR 110.0076
SER 120.0208
LYS 130.0457
PRO 140.0191
PHE 150.0133
HIS 160.0306
PRO 170.0311
LYS 180.0394
PHE 190.0223
ILE 200.0148
LYS 210.0375
GLU 220.0418
LEU 230.0238
ARG 240.0197
VAL 250.0200
ILE 260.0132
GLU 270.0355
SER 280.0292
GLY 290.0266
PRO 300.0107
HIS 310.0130
CYS 320.0207
ALA 330.0191
ASN 340.0101
THR 350.0185
GLU 360.0074
ILE 370.0072
ILE 380.0158
VAL 390.0145
LYS 400.0158
LEU 410.0228
SER 420.0357
ASP 430.0612
GLY 440.0186
ARG 450.0359
GLU 460.0358
LEU 470.0302
CYS 480.0259
LEU 490.0115
ASP 500.0137
PRO 510.0080
LYS 520.0059
GLU 530.0136
ASN 540.0101
TRP 550.0157
VAL 560.0083
GLN 570.0190
ARG 580.0205
VAL 590.0118
VAL 600.0145
GLU 610.0196
LYS 620.0074
PHE 630.0043
LEU 640.0113
LYS 650.0194
ARG 660.0247
ALA 670.0275
GLU 680.0333
ASN 690.0245

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.